Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer

BACKGROUND & AIMS: Although hepatocellular cancers (HCC) frequently arise in the setting of fibrosis and a hepatic regenerative response requiring new cell growth, therapeutic strategies for these cancers have not targeted protein synthesis. Silvestrol, a rocaglate isolated from Aglaia foveolata...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogure, Takayuki, Kinghorn, A. Douglas, Yan, Irene, Bolon, Brad, Lucas, David M., Grever, Michael R., Patel, Tushar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784426/
https://www.ncbi.nlm.nih.gov/pubmed/24086701
http://dx.doi.org/10.1371/journal.pone.0076136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784426/
https://www.ncbi.nlm.nih.gov/pubmed/24086701
http://dx.doi.org/10.1371/journal.pone.0076136

Ejemplares similares